HRP20140706T1 - Sastavi viralnih inhibitora za in vivo terapeutsku upotrebu koji ukljuäśuju kombinaciju (-)-karvona, (+)-karvona, geraniola i daljnju komponentu esencijalnog ulja - Google Patents
Sastavi viralnih inhibitora za in vivo terapeutsku upotrebu koji ukljuäśuju kombinaciju (-)-karvona, (+)-karvona, geraniola i daljnju komponentu esencijalnog ulja Download PDFInfo
- Publication number
- HRP20140706T1 HRP20140706T1 HRP20140706AT HRP20140706T HRP20140706T1 HR P20140706 T1 HRP20140706 T1 HR P20140706T1 HR P20140706A T HRP20140706A T HR P20140706AT HR P20140706 T HRP20140706 T HR P20140706T HR P20140706 T1 HRP20140706 T1 HR P20140706T1
- Authority
- HR
- Croatia
- Prior art keywords
- human
- composition
- disease
- carvone
- virus
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims 10
- ULDHMXUKGWMISQ-VIFPVBQESA-N (+)-carvone Chemical compound CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 title claims 4
- ULDHMXUKGWMISQ-SECBINFHSA-N (-)-carvone Chemical compound CC(=C)[C@@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-SECBINFHSA-N 0.000 title claims 4
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Natural products CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 title claims 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 title claims 3
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 title claims 3
- 239000003443 antiviral agent Substances 0.000 title claims 3
- 239000005792 Geraniol Substances 0.000 title 1
- 229940113087 geraniol Drugs 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000000341 volatile oil Substances 0.000 title 1
- 208000010201 Exanthema Diseases 0.000 claims 6
- 201000005884 exanthem Diseases 0.000 claims 6
- 208000015181 infectious disease Diseases 0.000 claims 6
- 206010037844 rash Diseases 0.000 claims 6
- 230000001154 acute effect Effects 0.000 claims 5
- 208000023504 respiratory system disease Diseases 0.000 claims 5
- 208000009714 Severe Dengue Diseases 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 208000006454 hepatitis Diseases 0.000 claims 4
- 208000006820 Arthralgia Diseases 0.000 claims 3
- 206010012310 Dengue fever Diseases 0.000 claims 3
- 201000004624 Dermatitis Diseases 0.000 claims 3
- 208000005577 Gastroenteritis Diseases 0.000 claims 3
- 206010037660 Pyrexia Diseases 0.000 claims 3
- 206010014599 encephalitis Diseases 0.000 claims 3
- 206010008909 Chronic Hepatitis Diseases 0.000 claims 2
- 206010010741 Conjunctivitis Diseases 0.000 claims 2
- 241000709687 Coxsackievirus Species 0.000 claims 2
- 241000450599 DNA viruses Species 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 201000005866 Exanthema Subitum Diseases 0.000 claims 2
- 208000007514 Herpes zoster Diseases 0.000 claims 2
- 241001243761 Human hepatitis A virus Species 0.000 claims 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 201000002950 dengue hemorrhagic fever Diseases 0.000 claims 2
- 201000009892 dengue shock syndrome Diseases 0.000 claims 2
- 230000002458 infectious effect Effects 0.000 claims 2
- 201000006747 infectious mononucleosis Diseases 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 230000003902 lesion Effects 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Substances 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 claims 1
- 208000003829 American Hemorrhagic Fever Diseases 0.000 claims 1
- 208000000058 Anaplasia Diseases 0.000 claims 1
- 201000009695 Argentine hemorrhagic fever Diseases 0.000 claims 1
- 208000034200 Bolivian hemorrhagic fever Diseases 0.000 claims 1
- 208000014644 Brain disease Diseases 0.000 claims 1
- 201000010424 Brazilian hemorrhagic fever Diseases 0.000 claims 1
- 208000009458 Carcinoma in Situ Diseases 0.000 claims 1
- 201000006082 Chickenpox Diseases 0.000 claims 1
- 206010008531 Chills Diseases 0.000 claims 1
- 206010010071 Coma Diseases 0.000 claims 1
- 206010011834 Cytomegalovirus mononucleosis Diseases 0.000 claims 1
- 241001533413 Deltavirus Species 0.000 claims 1
- 208000001490 Dengue Diseases 0.000 claims 1
- 206010058314 Dysplasia Diseases 0.000 claims 1
- 208000032274 Encephalopathy Diseases 0.000 claims 1
- 208000004232 Enteritis Diseases 0.000 claims 1
- 241001529459 Enterovirus A71 Species 0.000 claims 1
- 241000693328 Enterovirus B69 Species 0.000 claims 1
- 241000991587 Enterovirus C Species 0.000 claims 1
- 208000035751 Epidemic nephropathy Diseases 0.000 claims 1
- 206010066919 Epidemic polyarthritis Diseases 0.000 claims 1
- 206010015108 Epstein-Barr virus infection Diseases 0.000 claims 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 claims 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 claims 1
- 206010017964 Gastrointestinal infection Diseases 0.000 claims 1
- 206010061192 Haemorrhagic fever Diseases 0.000 claims 1
- 206010019233 Headaches Diseases 0.000 claims 1
- 208000032982 Hemorrhagic Fever with Renal Syndrome Diseases 0.000 claims 1
- 201000006219 Herpangina Diseases 0.000 claims 1
- 208000000903 Herpes simplex encephalitis Diseases 0.000 claims 1
- 208000017604 Hodgkin disease Diseases 0.000 claims 1
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims 1
- 241000699727 Human echovirus Species 0.000 claims 1
- 241000709694 Human parechovirus 1 Species 0.000 claims 1
- 241001214603 Human rhinovirus A1 Species 0.000 claims 1
- 241000178583 Human rhinovirus B3 Species 0.000 claims 1
- 208000004044 Hypesthesia Diseases 0.000 claims 1
- 208000019637 Infantile Diarrhea Diseases 0.000 claims 1
- 206010021882 Infections and infestations congenital Diseases 0.000 claims 1
- 208000007766 Kaposi sarcoma Diseases 0.000 claims 1
- 206010023424 Kidney infection Diseases 0.000 claims 1
- BRHDDEIRQPDPMG-UHFFFAOYSA-N Linalyl oxide Chemical compound CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 claims 1
- 206010024971 Lower respiratory tract infections Diseases 0.000 claims 1
- 208000008771 Lymphadenopathy Diseases 0.000 claims 1
- 201000005505 Measles Diseases 0.000 claims 1
- 201000009906 Meningitis Diseases 0.000 claims 1
- 206010054949 Metaplasia Diseases 0.000 claims 1
- 208000005647 Mumps Diseases 0.000 claims 1
- 208000000112 Myalgia Diseases 0.000 claims 1
- 208000009525 Myocarditis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000001388 Opportunistic Infections Diseases 0.000 claims 1
- 206010048685 Oral infection Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 206010033799 Paralysis Diseases 0.000 claims 1
- 206010036030 Polyarthritis Diseases 0.000 claims 1
- 102000029797 Prion Human genes 0.000 claims 1
- 108091000054 Prion Proteins 0.000 claims 1
- 206010037596 Pyelonephritis Diseases 0.000 claims 1
- 206010037742 Rabies Diseases 0.000 claims 1
- 206010037868 Rash maculo-papular Diseases 0.000 claims 1
- 208000007313 Reproductive Tract Infections Diseases 0.000 claims 1
- 241000369753 Sapporo virus Species 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 claims 1
- 241000714208 Southampton virus Species 0.000 claims 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 claims 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 claims 1
- 206010042566 Superinfection Diseases 0.000 claims 1
- 208000037386 Typhoid Diseases 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 206010046980 Varicella Diseases 0.000 claims 1
- 201000009693 Venezuelan hemorrhagic fever Diseases 0.000 claims 1
- 231100000354 acute hepatitis Toxicity 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 206010064097 avian influenza Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 210000004087 cornea Anatomy 0.000 claims 1
- 208000025729 dengue disease Diseases 0.000 claims 1
- 239000000645 desinfectant Substances 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 201000010582 ecthyma Diseases 0.000 claims 1
- 201000006061 fatal familial insomnia Diseases 0.000 claims 1
- 231100000869 headache Toxicity 0.000 claims 1
- 230000002949 hemolytic effect Effects 0.000 claims 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims 1
- 208000034783 hypoesthesia Diseases 0.000 claims 1
- 208000033065 inborn errors of immunity Diseases 0.000 claims 1
- 210000003000 inclusion body Anatomy 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 206010023332 keratitis Diseases 0.000 claims 1
- 201000010666 keratoconjunctivitis Diseases 0.000 claims 1
- 201000002364 leukopenia Diseases 0.000 claims 1
- 231100001022 leukopenia Toxicity 0.000 claims 1
- 208000018555 lymphatic system disease Diseases 0.000 claims 1
- 208000012965 maculopapular rash Diseases 0.000 claims 1
- 230000015689 metaplastic ossification Effects 0.000 claims 1
- 210000004400 mucous membrane Anatomy 0.000 claims 1
- 208000010805 mumps infectious disease Diseases 0.000 claims 1
- 208000013465 muscle pain Diseases 0.000 claims 1
- 201000009240 nasopharyngitis Diseases 0.000 claims 1
- 231100000862 numbness Toxicity 0.000 claims 1
- 201000005737 orchitis Diseases 0.000 claims 1
- 208000003154 papilloma Diseases 0.000 claims 1
- 208000030428 polyarticular arthritis Diseases 0.000 claims 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 208000007056 sickle cell anemia Diseases 0.000 claims 1
- 201000010153 skin papilloma Diseases 0.000 claims 1
- 208000003265 stomatitis Diseases 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 201000008297 typhoid fever Diseases 0.000 claims 1
- 230000036269 ulceration Effects 0.000 claims 1
- 208000005925 vesicular stomatitis Diseases 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Claims (6)
1. Sastav koji se sastoji od
(-)-Karvona i
(+)-Karvona i
Trans-Geraniola i
barem još jedne komponente izabrane od
Eugenol metiletera i
Linalooloksida i
(cis+trans)-1,2-(+)-Limonen oksida i
Lavendulola
u farmaceutski učinkovitoj koncentraciji
za upotrebu u liječenju i prevenciji bolesti uzrokovanih virusima obavijenim sa DNK, virusima neobavijenim sa DNK, virusima obavijenim sa RNK, virusima neobavijenim sa DNK, koje bolesti su odabrane iz skupine koja se sastoji od:
(bronho)-pneumonije, 3-dnevne groznice egzantema, akutnog i kroničnog hepatitisa, akutne groznice, akutnog gastroenteritisa uzrokovanog naporima kao što je Desert Shield Lordsdale Mexico Norwalk Hawaii Snow Mountain Southampton virus, akutnog gastroenteritisa uzrokovanog naporima kao što je Houston/86 Houston/90 London 29845 Manchester Parkville Sapporo virus, akutnog hepatitisa, sindroma akutne respiratorne boli, AIDS-a, argentinske hemoragijske groznice, artralgije, ptičje gripe, bolivijske hemoragijske groznice, brazilske hemoragijske groznice, vodenih kozica, kroničnog hepatitisa, kome, infekcije prehladom, simptoma prehlade, kongenitalne infekcije, konjuktivitisa, zarazne ektime, zaraznog bubuljičavog dermatitisa, rožnjače, kriptične tifusne infekcije, citomegalovirusne mononukleoze, denga hemoragijske groznice (DHF), denga šok sindroma (DSS), proljeva, egzema, egzema herpatikum, encefalitisa, encefalopatije, enteritisa, epidemijske nefropatije, epidemijskog poliartritisa i egzantema, epidermodisplazije veruciformis, Epstein-Barr virusne infekcije, egzantema, egzantema kod djece, fatalne obiteljske insomnije, febrilnog encefalitisa, febrilne bolesti, groznice, nekadašnjeg humanog echo virusa 22 23, gastroenteritisa, gastrointestinalnih infekcija intracitoplazmičkim uključujućim tijelima, infekcija genitalnog trakta, hemolitičke krize kod ljudi sa bolešću srpastih stanica, glavobolja, hemoragijske groznice, hemoragijske groznice sa renalnim sindromom, herpesnog encefalitisa, Hodgkinove bolesti, humanog koksaki virusa, humanog koksaki virusa B1-6, humanog echo virusa 1-7 9 11-21 24-27 29-33, humanog enterovirusa 69, humanog enterovirusa 71 (bolest ruku, stopala i usta), humanog virusa hepatitisa A (HHAV), humanog polio virusa, humanog rinovirusa 1 2 7 9 11 15 16 21 29 36 39 49 50 58 62 65 85 89, hiperakutne respiratorne bolesti, humanog rinovirusa 3 14 72, hiperakutne respiratorne bolesti, sindroma imunodeficijencije, infantilnog proljeva, infekcije sa bilo kojim denga serotipom (1-4), infektivne mononukleoze, bolova u zglobovima, Kaposijevog sarkoma, keratokonjuktivitisa, lezija kutanoznih područja, leukopenije, ciroze jetre, infekcije donjeg dišnog trakta, limfadenopatije, makulopapularnog osipa, ospica, meningitisa, mononukleoze (bolesti ljubljenja), zaušnjaka, bolova mišića, miokarditisa, nefropatije, nefropatije kod transplantiranih pacijenata, obamrlosti, oportunističke infekcije, oralnih infekcija, orkitisa, pankreatitisa, pandemika, papiloma, paralize, otporne infekcije bubrega, otpornih infekcija, otporne limfopatije, faringealnog konjuktivitisa, upale pluća, primarnog hepatocelularnog karcinoma, pulmonarnog sindroma, bjesnoće, osipa, recidivne epidemije respiratorne bolesti, respiratorne bolesti, respiratornih oboljenja, rozeole infantum, sarkoma, ozbiljne artralgije s drhtavicom, ozbiljnog akutnog respiratornog sindroma, ozbiljnog encefalitisa, herpes zostera, šeste bolesti, lezija kože i mukozne membrane, bolesti mršavljenja, bolnog grla, subakutnog skleroznog panencefalitisa, superinfekcije sa Deltavirusom, ulceracije, bolesti gornjeg dišnog trakta, venecuelanske hemoragijske groznice, vezikularnog faringitisa, vezikularnog stomatitisa sa egzantemom, virusnog poliartritisa i navale, virusnih bradavica, vodenog proljeva, slabosti, zoonotika, zostera, metaplazije, displazije, anaplazije, dezmoplazije, in situ karcinoma, gripe (influence), invazivnog karcinoma.
2. Sastav za upotrebu temeljem zahtjeva 1, pri čemu se sastav koristi kao profilaktik.
3. Sastav za upotrebu temeljem zahtjeva 1, pri čemu se sastav koristi kao virusni inhibitor unutar tijela.
4. Sastav za upotrebu temeljem zahtjeva 1, pri čemu se sastav daje, oralno, topikalno, inhalacijom, supozitorijem, intravenozno, potkožno ili intramuskularno.
5. Upotreba sastava temeljem zahtjeva 1 kao dezinficijensa.
6. Upotreba sastava temeljem zahtjeva 1 kao virusnog inhibitora izvan tijela.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10157930A EP2368547B1 (en) | 2010-03-26 | 2010-03-26 | Antiviral compositions comprising geraniol and carvone |
| PCT/EP2011/054758 WO2011117424A1 (en) | 2010-03-26 | 2011-03-28 | Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-) -carvone, geraniol and a further essential oil component |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20140706T1 true HRP20140706T1 (hr) | 2014-09-12 |
Family
ID=42102951
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120964AT HRP20120964T1 (en) | 2010-03-26 | 2012-11-27 | Antiviral compositions comprising geraniol and carvone |
| HRP20140706AT HRP20140706T1 (hr) | 2010-03-26 | 2014-07-22 | Sastavi viralnih inhibitora za in vivo terapeutsku upotrebu koji ukljuäśuju kombinaciju (-)-karvona, (+)-karvona, geraniola i daljnju komponentu esencijalnog ulja |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120964AT HRP20120964T1 (en) | 2010-03-26 | 2012-11-27 | Antiviral compositions comprising geraniol and carvone |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US8980945B2 (hr) |
| EP (2) | EP2368547B1 (hr) |
| JP (1) | JP5342085B2 (hr) |
| KR (1) | KR101340260B1 (hr) |
| CN (1) | CN102946876B (hr) |
| AU (1) | AU2011231511B2 (hr) |
| BR (1) | BR112012024260B1 (hr) |
| CA (1) | CA2790087C (hr) |
| CL (1) | CL2012002606A1 (hr) |
| CO (1) | CO6602166A2 (hr) |
| CY (3) | CY1113449T1 (hr) |
| DK (2) | DK2368547T3 (hr) |
| EA (1) | EA025278B9 (hr) |
| ES (2) | ES2392938T3 (hr) |
| HK (1) | HK1176019A1 (hr) |
| HR (2) | HRP20120964T1 (hr) |
| HU (1) | HUE026121T2 (hr) |
| IL (1) | IL222048A (hr) |
| LU (1) | LU91805B1 (hr) |
| MA (1) | MA34074B1 (hr) |
| ME (1) | ME02035B (hr) |
| MX (1) | MX346412B (hr) |
| MY (2) | MY153104A (hr) |
| NZ (1) | NZ602602A (hr) |
| PE (2) | PE20130065A1 (hr) |
| PL (2) | PL2368547T3 (hr) |
| PT (2) | PT2368547E (hr) |
| RS (2) | RS52544B (hr) |
| SG (1) | SG184039A1 (hr) |
| SI (2) | SI2368547T1 (hr) |
| SM (2) | SMT201200062B (hr) |
| TN (2) | TN2012000444A1 (hr) |
| UA (1) | UA102497C2 (hr) |
| WO (1) | WO2011117424A1 (hr) |
| ZA (2) | ZA201208116B (hr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2773315B1 (en) | 2011-11-03 | 2015-07-08 | Unilever N.V. | A personal cleaning composition |
| MX354483B (es) | 2011-12-06 | 2018-03-07 | Unilever Nv | Composición antimicrobiana. |
| EA026135B1 (ru) | 2011-12-06 | 2017-03-31 | Юнилевер Н.В. | Противомикробная композиция |
| CN113545345A (zh) | 2011-12-06 | 2021-10-26 | 联合利华知识产权控股有限公司 | 抗微生物组合物 |
| IN2014MN02378A (hr) | 2012-06-27 | 2015-08-14 | Unilever Plc | |
| RU2533254C2 (ru) * | 2012-12-29 | 2014-11-20 | Федеральное государственное бюджетное учреждение научно-исследовательский институт детских инфекций Федерального медико-биологического агентства | Способ лечения неврологических осложнений при ветряной оспе у детей |
| TWI463979B (zh) * | 2013-04-12 | 2014-12-11 | Nat Defense Medical Ct | 檸檬醛用於製備治療局部腎絲球硬化症之藥物的用途 |
| KR20150145314A (ko) | 2014-06-18 | 2015-12-30 | 원광대학교산학협력단 | 카르본을 유효성분으로 포함하는 항균 조성물 |
| CN106727628A (zh) * | 2016-12-17 | 2017-05-31 | 郑州郑先医药科技有限公司 | 一种治疗慢性腹泻的西药组合物 |
| KR101970281B1 (ko) * | 2017-07-28 | 2019-04-18 | 고려대학교 산학협력단 | 리나릴 아세테이트를 포함하는 올메사탄으로 유발된 장운동과다증의 예방 또는 치료용 조성물 |
| CN107648488A (zh) * | 2017-09-29 | 2018-02-02 | 陈晓阳 | 一种用于治疗慢性咽炎的丸剂 |
| KR102118181B1 (ko) * | 2018-06-12 | 2020-06-02 | 광주여자대학교 산학협력단 | 식물성 정유를 유효성분으로 포함하는 a형 인플루엔자 바이러스에 대한 항바이러스 조성물 |
| RU2707950C1 (ru) * | 2018-11-28 | 2019-12-02 | Общество с ограниченной ответственностью "ЭРБИ" | Средство для обработки среды пребывания птицы на основе липосом с фитокомпозицией с иммунотропным действием и избирательным антисептическим эффектом и способ его применения |
| US20200179299A1 (en) * | 2018-12-07 | 2020-06-11 | Global Biolife Inc. | Composition and method of controlling infectious diseases with functional fragrances |
| CN110496117B (zh) * | 2019-09-30 | 2022-09-06 | 中国科学院微生物研究所 | 一种小分子化合物在抗非洲猪瘟病毒感染中的新应用 |
| CN111012769B (zh) * | 2019-12-05 | 2021-02-12 | 青海大学 | 一种用于治疗包虫病的药物组合物、药物制剂及乳剂制备方法 |
| WO2021224947A1 (en) * | 2020-05-02 | 2021-11-11 | Norouzi Mehdi | Formulation of acute respiratory disease control formulation |
| CN114702376A (zh) * | 2020-12-14 | 2022-07-05 | 中南民族大学 | 柏木醇衍生物、其制备方法及其应用 |
| CA3102947A1 (en) * | 2020-12-18 | 2022-06-18 | Skymount Medical Us Inc. | Nutraceuticals useful in the treatment of coronavirus diseases |
| JP7133820B1 (ja) * | 2021-06-09 | 2022-09-09 | 塩野香料株式会社 | コロナウイルス感染症予防用香料組成物及び結合阻害剤 |
| CN113994963B (zh) * | 2021-09-26 | 2023-04-28 | 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) | 一种含有乙酸二氢香芹酯的抑芽剂及其用途 |
| TWI800937B (zh) * | 2021-10-01 | 2023-05-01 | 奇美醫療財團法人奇美醫院 | 用於治療登革熱病毒感染之方法 |
| WO2024097158A1 (en) * | 2022-11-01 | 2024-05-10 | Ramirez Christina M | Viral prophylaxis treatment methods and pre-exposure prophylaxis kits |
| CN117338758B (zh) * | 2023-12-06 | 2024-03-12 | 北京远大九和药业有限公司 | 一种药物组合物及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR5667M (hr) | 1966-03-10 | 1968-01-02 | ||
| LU78955A1 (de) * | 1978-01-27 | 1979-09-06 | Chimicasa Gmbh | Verfahren zur inaktivierung von viren |
| US4902678A (en) * | 1982-02-12 | 1990-02-20 | Syntex (U.S.A.) Inc. | Anti-viral compositions |
| US5856364A (en) * | 1991-03-01 | 1999-01-05 | Warner Lambert Company | Therapeutic antiviral-wound healing compositions and methods for preparing and using same |
| US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
| WO2002056879A1 (en) * | 2001-01-03 | 2002-07-25 | Medpharma Plc | Use of terpenes for the treatment of digestive tract infections |
| US20040071757A1 (en) * | 2001-11-20 | 2004-04-15 | David Rolf | Inhalation antiviral patch |
| KR20140103191A (ko) * | 2005-11-30 | 2014-08-25 | 에덴 리서치 피엘씨 | 티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법 |
| US9403126B2 (en) * | 2007-01-10 | 2016-08-02 | The Regents Of The University Of Michigan | Ultrafiltration membrane, device, bioartificial organ, and related methods |
| KR100796312B1 (ko) * | 2007-05-23 | 2008-01-21 | 주식회사 바이오미스트테크놀로지 | 게라니얼，네랄 및 유게놀을 유효성분으로 함유하는 동물용소독제 조성물 |
| KR100950428B1 (ko) | 2008-06-05 | 2010-04-02 | 주식회사 알앤엘바이오 | 바이러스 억제제로서 유용한 디아릴헵타노이드계 화합물 |
| KR100941595B1 (ko) | 2008-06-05 | 2010-02-11 | 주식회사 알앤엘바이오 | 바이러스 억제제로서 유용한 트리테르페노이드계 화합물 |
-
2010
- 2010-03-26 ES ES10157930T patent/ES2392938T3/es active Active
- 2010-03-26 RS RS20120533A patent/RS52544B/en unknown
- 2010-03-26 SI SI201030084T patent/SI2368547T1/sl unknown
- 2010-03-26 PL PL10157930T patent/PL2368547T3/pl unknown
- 2010-03-26 PT PT10157930T patent/PT2368547E/pt unknown
- 2010-03-26 DK DK10157930.8T patent/DK2368547T3/da active
- 2010-03-26 ME MEP-2012-533A patent/ME02035B/me unknown
- 2010-03-26 EP EP10157930A patent/EP2368547B1/en active Active
-
2011
- 2011-03-28 SG SG2012067724A patent/SG184039A1/en unknown
- 2011-03-28 MA MA35226A patent/MA34074B1/fr unknown
- 2011-03-28 MX MX2012010949A patent/MX346412B/es active IP Right Grant
- 2011-03-28 SI SI201130216T patent/SI2555763T1/sl unknown
- 2011-03-28 EA EA201270749A patent/EA025278B9/ru unknown
- 2011-03-28 ES ES11710232.7T patent/ES2486765T3/es active Active
- 2011-03-28 WO PCT/EP2011/054758 patent/WO2011117424A1/en active Application Filing
- 2011-03-28 MY MYPI2012004074 patent/MY153104A/en unknown
- 2011-03-28 AU AU2011231511A patent/AU2011231511B2/en active Active
- 2011-03-28 KR KR1020127027321A patent/KR101340260B1/ko active IP Right Grant
- 2011-03-28 CN CN201180026050.1A patent/CN102946876B/zh active Active
- 2011-03-28 EP EP11710232.7A patent/EP2555763B1/en active Active
- 2011-03-28 US US13/582,784 patent/US8980945B2/en active Active
- 2011-03-28 NZ NZ602602A patent/NZ602602A/xx unknown
- 2011-03-28 DK DK11710232.7T patent/DK2555763T3/da active
- 2011-03-28 BR BR112012024260A patent/BR112012024260B1/pt active IP Right Grant
- 2011-03-28 CA CA2790087A patent/CA2790087C/en active Active
- 2011-03-28 UA UAA201212244A patent/UA102497C2/ru unknown
- 2011-03-28 RS RS20140380A patent/RS53435B/en unknown
- 2011-03-28 LU LU91805A patent/LU91805B1/fr active
- 2011-03-28 PL PL11710232T patent/PL2555763T3/pl unknown
- 2011-03-28 PE PE2012001578A patent/PE20130065A1/es active IP Right Grant
- 2011-03-28 PT PT117102327T patent/PT2555763E/pt unknown
- 2011-03-28 JP JP2013500539A patent/JP5342085B2/ja active Active
- 2011-09-27 PE PE2013002126A patent/PE20141008A1/es active IP Right Grant
- 2011-09-27 MY MYPI2013003352A patent/MY158757A/en unknown
- 2011-09-27 HU HUE11761085A patent/HUE026121T2/en unknown
-
2012
- 2012-09-12 TN TNP2012000444A patent/TN2012000444A1/en unknown
- 2012-09-19 CO CO12162165A patent/CO6602166A2/es not_active Application Discontinuation
- 2012-09-20 IL IL222048A patent/IL222048A/en active IP Right Grant
- 2012-09-21 CL CL2012002606A patent/CL2012002606A1/es unknown
- 2012-10-26 ZA ZA2012/08116A patent/ZA201208116B/en unknown
- 2012-11-27 HR HRP20120964AT patent/HRP20120964T1/hr unknown
- 2012-12-10 CY CY20121101200T patent/CY1113449T1/el unknown
- 2012-12-24 SM SM201200062T patent/SMT201200062B/xx unknown
-
2013
- 2013-03-21 HK HK13103557.4A patent/HK1176019A1/xx unknown
- 2013-09-16 TN TNP2013000366A patent/TN2013000366A1/fr unknown
- 2013-09-16 ZA ZA2013/06926A patent/ZA201306926B/en unknown
-
2014
- 2014-07-14 US US14/331,131 patent/US8883859B1/en active Active
- 2014-07-22 HR HRP20140706AT patent/HRP20140706T1/hr unknown
- 2014-07-29 CY CY20141100573T patent/CY1115375T1/el unknown
- 2014-07-31 SM SM201400104T patent/SMT201400104B/xx unknown
-
2015
- 2015-05-29 CY CY20151100478T patent/CY1119841T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20140706T1 (hr) | Sastavi viralnih inhibitora za in vivo terapeutsku upotrebu koji ukljuäśuju kombinaciju (-)-karvona, (+)-karvona, geraniola i daljnju komponentu esencijalnog ulja | |
| RU2019118390A (ru) | Производное пиразоло-гетероарила, способ его получения и медицинское применение | |
| JP2015525220A5 (hr) | ||
| NO20092742L (no) | 4,5-ringkondenserte indolderivater for behandling eller forebyggelse av HCV og beslektede virusinfeksjoner | |
| Du et al. | The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis | |
| EA035439B1 (ru) | Амидное соединение и его применение в качестве средства для лечения и профилактики заболеваний, вызываемых рнк- и/или днк-содержащими вирусами, и сопутствующих заболеваний | |
| Hersoug | Viruses as the causative agent related to ‘dampness’ and the missing link between allergen exposure and onset of allergic disease. | |
| de Patología Digestiva et al. | Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18) | |
| HRP20150596T1 (hr) | Sastav viralnih inhibitora za in vivo terapeutsku upotrebu | |
| JP3598168B2 (ja) | 抗ウイルス剤 | |
| Parvez | Gut feeling: the plausible fecal-oral transmission route of COVID-19 | |
| Mizuta et al. | Phylogenetic and cluster analysis of human rhinovirus species A (HRV-A) isolated from children with acute respiratory infections in Yamagata, Japan | |
| Kaiser et al. | Editorial response: rhinovirus pneumonia: a clinical entity? | |
| CN118076589A (zh) | 一种酰胺类化合物、其制备方法和制药用途 | |
| Jhawar | Severe bronchiolitis in children | |
| Cruz-Jiménez et al. | An Overview of Antivirals for Treating Lower Respiratory Tract Infections | |
| Abdo et al. | Fatal 2009 pandemic influenza A (H1N1) in a bone marrow transplant recipient | |
| Rodriguez | Covid-19: A fecal-orally transmitted disease with severe involvement of the lungs | |
| Chaudhari et al. | A review on pandemic disease Covid-19: structure, pathophysiology, epidemiology and treatment | |
| Tarrass | Avian pandemic: Is there a potential concern for nephrologists? | |
| CN112891329B (zh) | 萜类化合物在制备抗流感病毒药物中的应用 | |
| Meqdam | AUTHORPS REPLY | |
| Lee et al. | A study about the relation between elev ated transaminase lev el and severity of viral lower respiratory tract infection in children | |
| Macconnachie et al. | Three men, a paint brush and a coronavirus | |
| Kang et al. | Epidemiology of acute viral resp iratory tract infections in Busan (2004-2006) |